title: Metabolic abnormalities in the pathogenesis of type 1 diabetes.
abstract: Clinical onset of type 1 diabetes (T1D) is thought to result from a combination of overt beta cell loss and beta cell dysfunction. However, our understanding of how beta cell metabolic abnormalities arise during the pathogenesis of disease remains incomplete. Despite extensive research on the autoimmune nature of T1D, questions remain regarding the time frame and nature of beta cell destruction and dysfunction. This review focuses on the characterizations of beta cell dysfunction in the prediabetic and T1D human and mouse model. Studies have shown evidence supporting progressive loss of beta cell mass and function prior to T1D onset, while other scientists argue beta cell destruction occurs later in the disease process. Determining the time frame of beta cell destruction and identifying metabolic mechanisms that drive beta cell dysfunction has high potential for successful interventions to maintain insulin secretion for individuals with established T1D as well as those with prediabetes.
authors.affiliation: Department of Pathology, Immunology, and Laboratory Medicine, The University of Florida College of Medicine, University of Florida, 1275 Center Dr, Room J597, Gainesville, FL, 32610-0275, USA.
authors.forename: Shuyao
authors.initials: S
authors.lastname: Zhang
authors.forename: Clayton E
authors.initials: CE
authors.lastname: Mathews
mesh_terms: D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000378:metabolism*; D004195:Disease Models, Animal; D006801:Humans; D050417:Insulin-Secreting Cells / Q000378:metabolism / Q000473:pathology